ORY — ORYZON Genomics SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for ORYZON Genomics SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	35.3	39.6	28.7	21.3	12.3
Net Total Accounts Receivable
Net Total Receivables	2.2	2.46	3.78	3.84	2.01
Total Inventory
Total Current Assets	37.7	42.4	32.6	25.2	14.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.631	0.644	0.682	0.611	0.481
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	80.1	94.1	95.4	104	107
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	10.5	7.69	8.67	18.7	16.4
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	19	18.2	24.1	31.1	25.1
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	61.1	75.9	71.3	72.6	81.8
Total Liabilities & Shareholders' Equity	80.1	94.1	95.4	104	107
Total Common Shares Outstanding